TriSalus Life Sciences Warrant

TLSIW

Market cap $27.8M

TLSIW Hedge Fund Activity: Q1 2026 in Review

7 of the 8,126 institutional investors tracked by Wall St. Rank reported a position in TriSalus Life Sciences Warrant (TLSIW) for Q1 2026, worth a combined $1.23M — down 30% from $1.77M a quarter earlier.

Sellers outnumbered buyers: 2 funds closed out of TLSIW and 1 opened new positions — a net loss of 1 holder — while 2 trimmed existing stakes and 1 added.

The largest buyer was Aristeia Capital, adding an estimated $741. The largest seller was Wolverine Asset Management, exiting entirely with an estimated $51.4K sold.

• 7 institutional investors held TriSalus Life Sciences Warrant (TLSIW) as of Q1 2026, down from 8 in Q4 2025.
• Funds reported $1.23M of TriSalus Life Sciences Warrant stock for Q1 2026, down 30% quarter-over-quarter.
• 1 fund opened new TriSalus Life Sciences Warrant positions in Q1 2026 and 2 closed out, a net change of -1 holder.
• The largest TriSalus Life Sciences Warrant buyer in Q1 2026 was Aristeia Capital, an estimated $741 added.
• The largest TriSalus Life Sciences Warrant seller in Q1 2026 was Wolverine Asset Management, an estimated $51.4K sold.

Based on aggregated 13F filings for Q1 2026.